Obesity-related aromatase increases in adipose tissue and the whole body system, while hormone therapy lifestyle interventions including weight management and may reduce BC risk by decreasing levels of related hormones and aromatase. Here, CYP19A1 is linked to obesity due to melanocortin 4 receptor deficiency.